Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-25
2007-12-25
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S256000, C514S307000, C514S314000, C514S317000, C514S318000, C514S319000, C514S320000, C514S321000, C514S322000, C514S323000, C514S324000, C514S325000, C544S334000, C544S405000, C546S149000, C546S164000, C546S180000, C546S181000, C546S187000
Reexamination Certificate
active
10809772
ABSTRACT:
The present application describes modulators of CCR3 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
REFERENCES:
patent: 2684965 (1954-07-01), Weston et al.
patent: 3133061 (1964-05-01), Kirchner et al.
patent: 4943578 (1990-07-01), Naylor et al.
patent: 5116842 (1992-05-01), Naylor et al.
patent: 5512567 (1996-04-01), Terada et al.
patent: 5646151 (1997-07-01), Kruse et al.
patent: 5688955 (1997-11-01), Kruse et al.
patent: 5744458 (1998-04-01), Kruse et al.
patent: 5770735 (1998-06-01), Emonds-Alt et al.
patent: 6759411 (2004-07-01), Ko et al.
patent: 2013179 (1970-10-01), None
patent: 0747357 (1996-06-01), None
patent: 3163067 (1991-07-01), None
patent: 3163068 (1991-07-01), None
patent: 93/20099 (1993-10-01), None
patent: 95/19344 (1995-07-01), None
patent: 97/17954 (1997-05-01), None
patent: 97/22597 (1997-06-01), None
patent: 97/24324 (1997-07-01), None
patent: 97/48681 (1997-12-01), None
patent: 98/25604 (1998-06-01), None
patent: 98/25617 (1998-06-01), None
patent: 98/27815 (1998-07-01), None
patent: 98/31364 (1998-07-01), None
patent: 99/04794 (1999-02-01), None
patent: 99/09984 (1999-03-01), None
Khandelwal et al, Agents Acting on CNS, Indian J. Chem. 16B, pp. 1012-1014.
Birch et al., Preparation and Evaluation of Some Hydrophilic Phenylacetl-Piperazines as Peripherally Selective k-Opioid Receptor Agonists, Bioorganic & Medicinal Chemistry Letters, 1992, pp. 1275-1278, vol. 2, No. 10.
Naylor et al., A Potent New Class of k-Receptor Agonist: 4-Substututed 1-(Arylacetyle)-2-[(Dialkylamino)Methyl]Piperazines, J. Med. Chem., 1993, pp. 2075-2083, vol. 36.
Hesselgesser et al., Identification and Characterization of Small Molecule Functional Antagonists of the CCR1 Chemokine Receptor, The Journal of Biological Chemistry, 1998, pp. 15687-15692, vol. 273, No. 25.
Delucca George V.
Duncia John V.
Ko Soo S.
Santella III Joseph B.
Wacker Dean A.
Bristol-Myers Squibb Pharma Company
Habte Kahsay
VanAtten Mary K.
LandOfFree
Heterocyclic piperidines as modulators of chemokine receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic piperidines as modulators of chemokine receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic piperidines as modulators of chemokine receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3865822